X4 Pharmaceuticals, Inc. (XFOR) Revenue Growth
X4 Pharmaceuticals, Inc. (XFOR) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2019-12-31 | -99.60% |
| 2020-12-31 | 21328.57% |
| 2021-12-31 | -93.47% |
| 2022-12-31 | 0.00% |
| 2023-12-31 | -0.51% |
| 2024-12-31 | 1211.28% |
| 2025-12-31 | 1273.21% |
How XFOR compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc. | 627.84% |
| VTGN | Vistagen Therapeutics Inc. | 161.11% |
| ETON | Eton Pharmaceuticals Inc. | 104.94% |
| RGNX | REGENXBIO Inc. | 104.54% |
| TGTX | TG Therapeutics Inc. | 87.32% |
These are five companies in the same sector as XFOR with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get X4 Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("XFOR", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | XFOR | $3.51 | -3.04% | 0.97M |
| 3 | ||||
| 4 | ||||
| 5 |